Regulatory intelligence
TRT by country
Understand legal access, telemedicine constraints, diagnosis standards, and how many online or telehealth-accessible providers are currently tracked in each market.
United States
Schedule III Controlled Substance
Avg cost
$115-179
Providers
16 tracked
Telemedicine
Allowed
Diagnosis
Total testosterone < 300 ng/dL on two separate morning tests
Canada
Prescription Drug (Schedule F)
Avg cost
CAD $79-149
Providers
8 tracked
Telemedicine
Allowed
Diagnosis
Total testosterone < 7.5 nmol/L (216 ng/dL)
United Kingdom
Prescription Only Medicine (POM) / Class C Controlled Drug
Avg cost
Β£55-120
Providers
10 tracked
Telemedicine
Allowed
Diagnosis
Total testosterone < 8 nmol/L (231 ng/dL)
Germany
Prescription Only (verschreibungspflichtig) / Anlage III BtMG
Avg cost
β¬50-120
Providers
9 tracked
Telemedicine
Allowed
Diagnosis
Total testosterone < 12 nmol/L (346 ng/dL)
Australia
Schedule 4 Prescription Only Medicine (PBS listed)
Avg cost
AUD $125-200
Providers
12 tracked
Telemedicine
Allowed
Diagnosis
Total testosterone < 10 nmol/L (288 ng/dL) on two fasting morning tests